Le Lézard
Classified in: Health
Subjects: LBR, POL

Inside Rx Provides Savings on Influenza Medications


FRANKLIN LAKES, N.J., Feb. 5, 2018 /PRNewswire/ -- Inside Rx today announced that it is now offering better pricing on the brand and generic versions of Tamiflu® (oseltamivir phosphate) to help Americans affected by what the Centers for Disease Control and Prevention (CDC) has called the worst recorded influenza season in almost a decade. Launched last year by Express Scripts (NASDAQ: ESRX), the Inside RxSM prescription savings program can provide deeper savings to people who pay full-list price for prescription medications.

Working with the manufacturer, Genentech, Inside Rx is offering savings of up to 25 percent on brand-name Tamiflu, and through its network of 40,000 pharmacies, will offer a discount of up to 28 percent on generics as compared to their respective cash prices for eligible patients. 

"The addition of Tamiflu and generic oseltamivir phosphate to the catalog of discounted medications available through Inside Rx is another example of the meaningful value we can provide to Americans who pay out-of-pocket for their medications," said Inside Rx CEO Leslie Achter. "Having affordable access to a medication like Tamiflu during this severe flu season can make a difference for people who have an increased risk for flu complications."

According to the CDC, more than six percent of the country currently has the flu, and the virus is spreading rapidly, with 48 states and Puerto Rico showing high activity. In addition, they anticipate several more weeks of this flu season.

Dan Jernigan, M.D., M.P.H, director of the CDC's Influenza Division, recently stated: "For treatment, CDC recommends prompt treatment with flu antiviral drugs for people who are very sick with flu symptoms or people who are at high risk of developing serious flu complications when they get the flu."

To benefit from these discounts users simply need to download the free discount card from insiderx.com, or via GoodRx.com/brand, and present it at one of the 40,000 participating pharmacies located across the U.S. and Puerto Rico. These include national chains such as Kroger® Family of Pharmacies, CVS® and Walgreens®. There is no membership fee to benefit from the savings offered through Inside Rx, which also partners with GoodRx to connect patients with savings at the pharmacy.

About Tamiflu
Tamiflu is a prescription medicine used to treat the flu (influenza) in people 2 weeks of age and older who have had flu symptoms for no more than 2 days. Tamiflu can also reduce the chance of getting the flu in people 1 year and older.

Important Safety Information

Please see the Tamiflu full Prescribing Information for complete important safety information.

Patients are encouraged to report side effects to Genentech by calling 1-888-835-2555 or to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.

About Inside Rx
Headquartered in Franklin Lakes, New Jersey, Inside Rx provides affordable access to prescription medication for the uninsured and those navigating the changing healthcare landscape.

Powered by our parent company, Express Scripts, and working collaboratively across the pharmacy supply chain, Inside Rx delivers access to a broad list of branded medications that treat many common, chronic health conditions.

Visit www.insiderx.com, or follow us @Inside_Rx on Twitter, to learn more.

Media Contact:
Jennifer Luddy
(908) 794-9226
[email protected]

Ann Smith
Coyne Public Relations
(973) 588-2385
[email protected]

SOURCE Inside Rx


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...



News published on and distributed by: